Anatomy and physiology of venous system vascular access: Implications

Journal of Parenteral and Enteral Nutrition

Volumn 30, Issue SUPPL. 1, 2006, Pages

  Grant, John P ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTATION; ANATOMY; BED; BLOOD FLOW; BLOOD VESSEL OCCLUSION; CONFERENCE PAPER; FEMORAL VEIN; HEART RIGHT ATRIUM; HOME CARE; HUMAN; INFERIOR CAVA VEIN; INTERNAL JUGULAR VEIN; PHLEBITIS; PRIORITY JOURNAL; RISK REDUCTION; SAFETY; SUBCLAVIAN VEIN; VASCULAR ACCESS; VENOUS CIRCULATION; WOUND DRESSING;

CATHETERIZATION, CENTRAL VENOUS; CATHETERS, INDWELLING; FEMORAL VEIN; HUMANS; INFECTION CONTROL; JUGULAR VEINS; PARENTERAL NUTRITION; PHLEBITIS; SAFETY; SUBCLAVIAN VEIN; TIME FACTORS;

EID: 30744465916     PISSN: 01486071     EISSN: None     Source Type: Journal    
DOI: 10.1177/01486071060300S1S7     Document Type: Conference Paper

References (10)

1. Maki DG, Ringer M, Alvarado CJ. Prospective randomized trial of povidone-iodine, alcohol, and chlorhexidine for prevention of infection associated with central venous and arterial catheters. Lancet. 1991;338:339-343. Level 2 Evidence: Large study of 668 catheter placements in which disinfection of the site before insertion and site care every other day thereafter was randomized to either 10% povidoneiodine, 70% alcohol, or 2% aqueous chlorhexidine. Outcomes demonstrated statistically fewer local and systemic infections with us of chlorhexidine.
2. Humar A, Ostromecki A, Direnfeld J, et al. Prospective randomized trial of 10% povidone-iodine versus 0.5% tincture of chlorhexidine as cutaneous antisepsis for prevention of central venous catheter infection. Clin Infect Dis. 2000;31:1001-1007. Level 2 Evidence: A multicenter prospective, randomized, controlled trial, with 0.5% tincture of chlorhexidine vs 10% povidone-iodine in 374 catheterizations. There was no significant improvement in infections with this lower dose of chlorhexidine.
3. Bern MM, Lokich JJ, Wallach SR, et al. Very low doses of warfarin can prevent thrombosis in central venous catheters: a randomized prospective trial. Ann Intern Med. 1990;112:423-428. Level 2 Evidence: One hundred twenty-one patients entered the study, and 82 patients completed the study. Prospective randomization of patients to 1 mg warfarin daily or not demonstrated statistically lower thrombosis rates with use of warfarin.
4. Wilson S, Sparks W, Williams V, Grant J. Modification of patient positioning for subclavian catheter insertion [Abstract]. JPEN J Parenter Enteral Nutr 1990;14(suppl 1):S17. Abstract 66. Level 3 Evidence.
5. Land RE. Anatomic relationships of the right subclavian vein: a radiologic study pertinent to percutaneous subclavian venous catheterization. Arch Surg. 1971;102:178-180. Level 5 Evidence.
6. Land RR. The relationship of the left subclavian vein to the clavicle: practical considerations pertinent to the percutaneous catheterization of the subclavian vein. J Thorac Cardiovasc Surg. 1972;63:564-568. Level 5 Evidence.
7. Curtas S, Bonaventura M, Meguid MM. Cannulation of inferior vena cava for long term central venous access. Surg Gynecol Obstet. 1989;168:121-124. Level 5 Evidence.
8. Oram-Smith JC, Mullen JL, Harken AH, Fitts WT Jr. Direct right atrial catheterization for total parenteral nutrition. Surgery. 1978;83:274-276. Level 5 Evidence.
9. Denny DF, Dorfman GS, Greenwood LH, Horowitz NR, Morse SS. Translumbar inferior vena cava Hickman catheter placement for total parenteral nutrition. AJR Am J Roentgenol. 1987;148:621-622. Level 5 Evidence.
10. Azizkhan RG, Taylor LA, Jaques PF, Mauro MA, Lacey SR. Percutaneous translumbar and transhepatic inferior vena caval catheters for prolonged vascular access in children. J Pediatr Surg. 1992;27:165-169. Level 5 Evidence.